Company intelligence / Profile preview
Sumitomo Pharma America
Marlborough, MA, United Statesus.sumitomo-pharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
SMPA has a diverse pipeline with multiple assets in early to late-stage clinical development, including marketed products in CNS and other areas. Notable programs include lurasidone (LATUDA) for schizophrenia, DSP-0038 for Alzheimer’s disease psychosis, and regenerative cell-based approaches for Parkinson’s disease and retinal disorders. SMPA showcases clinical breadth in oncology, neurology, rare disease, and regenerative medicine, with ongoing pivotal and exploratory studies across regions.[2][5][7][8]
- Therapeutic areas
- OphthalmologyPsychiatryInfectious DiseasesHematologyOncologyNeurology
- Modalities
- Small moleculeMonoclonal antibodyGene therapyCell therapyRegenerative medicineBiologic
- Industry
- Biotech
02
Drug pipeline
18 assets17 more assets in the full pipeline.
Request access →03
Partnerships
Exscientia (AI drug discovery)RACTHERA Co., Ltd. (cell therapy development)Kyoto University CiRAUniversity of California San Diego School of MedicineHealiosMassachusetts Eye and Ear
Beyond the preview
Go deeper on Sumitomo Pharma America.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sumitomo Pharma America.